Episode 890: AAA Bonds vs The Market. Who Wins？ Valuating Astra Zeneca Pipeline
The Shkreli Pill - En podcast av Urban Tapes
Kategorier:
In this episode, Martin compares the stability of AAA bonds with the current state of the broader market, explaining how risk-adjusted returns stack up between the two. He also walks through his approach to valuing AstraZeneca’s drug pipeline, examining key assets, projected timelines, and the factors that shape his long-term outlook on the company.
